Scientists are rapidly examining retatrutide, a novel medication from Eli Lilly, as a significant step in body reduction . Distinct from many previous approaches, retatrutide is a dual -action receptor targeting simultaneously GLP-1 and GIP, hormones that affect hunger and blood sugar balance. E… Read More